66th ASH Annual Meeting: Trial Designs for Decentralized Clinical Trials

Symposia: Scientific Workshop on Decentralized Clinical Trials in Hematology: Reshaping the Traditional Clinical Trial Paradigm With AI Strategies for 'Real World' Patient Representation Scientific Workshops

Room 4 (San Diego Convention Center)

Moderator:

and Jean M. M Connors, MD, Brigham and Women's Hospital

Disclosures:

Connors: Abbott: Honoraria; Anthos: Honoraria; Bristol Myers Sqibb: Honoraria; Bayer: Honoraria; Janssen: Honoraria; Pfizer: Honoraria; Sanofi: Honoraria; Werfen: Honoraria; Perosphere: Honoraria.

Discuss the various trial designs for decentralized clinical trials, challenges for implementation of these trial designs and the regulatory questions that may arise with these trial designs.

Moderator Introduction

Jean M. M Connors, MD

Harvard Medical School, Brigham and Women's Hospital, Boston, MA

Are We Ready for Innovative Decentralized Clinical Trials in Hematology? Learnings from the COVID19 Pandemic

Jean M. M Connors, MD

Harvard Medical School, Brigham and Women's Hospital, Boston, MA

How Can AI Help in 'real World' Patient Selection?

Andrew Srisuwananukorn, MD

The Ohio State University, Columbus, OH

Using Wearables for Patient Monitoring in Decentralized Clinical Trials- Ready for Prime Time?

Shirley D'Sa, FRCP FRCPath MD(Res)

UCLH Centre for Waldenstrom Macroglobulinaemia and Related Conditions, University College London Hospitals NHS Foundation Trust, London, United Kingdom; UCLH Centre for Waldenström’s Macroglobulinemia and Related Conditions, University College London Hospitals NHS Foundation Trust, London, United Kingdom; UCL Cancer Institute, University College London, London, United Kingdom

Panel Discussion

See more of: Scientific Workshop on Decentralized Clinical Trials in Hematology: Reshaping the Traditional Clinical Trial Paradigm With AI Strategies for 'Real World' Patient Representation
See more of: Scientific Workshops

<< Previous Session | Next Session >>